She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Campaign launched to spread awareness regarding dengue prevention and control
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Natco Pharma intends to defend the matter accordingly
Cipla completes transfer of Generics Business Undertaking
The observations do not pose any risk to site's compliance standards or its business continuity
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Subscribe To Our Newsletter & Stay Updated
